Bilirubin Blood Test Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-24　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1.42 Bn
2033 年預估規模: USD 2.28 Bn
年複合成長率 CAGR: 7%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-06-24頁數 250報告編號 CMI9686

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Bilirubin Blood Test Market, By Test Type (Total Bilirubin Test, Direct Bilirubin Test, and Indirect Bilirubin Test), By Application (Liver Disease Diagnosis and Monitoring, Neonatal Jaundice Screening, Hemolytic Disorders, and Others), By End User (Hospitals, Diagnostic Laboratories, Physician Offices and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global bilirubin blood test market is estimated to be valued at USD 1.42 Bn in 2026 and is expected to reach USD 2.28 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7% from 2026 to 2033. The global bilirubin blood test market is a key segment of the in-vitro diagnostics (IVD) market, consisting of laboratory-based and point-of-care (POC) tests that analyze the amount of bilirubin in the blood, a component important for detecting and monitoring liver diseases, hemolytic disorders, bile tract conditions, and neonatal jaundice. Different bilirubin tests are classified as total bilirubin, direct bilirubin, and indirect bilirubin. The market growth is fueled by the escalating prevalence of chronic and acute liver diseases, as well as the rising occurrences of jaundice in newborns worldwide. In addition, increasing global efforts to promote early disease diagnostics, general health screenings and check-ups further drive adoption of bilirubin blood tests. Technological improvements in medical imaging, clinical lab equipment, and other medical testing instruments enable manufacturers to introduce advanced solutions for more accurate and precise results. Burgeoning healthcare infrastructure in developing countries can be anticipated to drive demand for bilirubin blood test solutions through the predicted timeline. Market Dynamics The global bilirubin blood test market is driven by growing prevalence of liver diseases such as hepatitis, cirrhosis and non-alcoholic fatty liver disease (NAFLD) which necessitates regular monitoring of bilirubin levels for diagnosis and management of conditions. Higher rate of neonatal jaundice has also contributed to the growth in the usage of these tests in hospitals and neonatal units. Furthermore, innovative and novel developments such as enhanced accuracy with point-of-care testing equipment, automatic analyzers and innovative and affordable non-invasive transcutaneous bilirubinometers are also leading to the demand for this test. However, a number of constraints are present in the market, such as high prices of cutting-edge diagnostic systems, lack of health coverage in remote areas, shortage of proficient lab workers, strict regulations for medical devices, and limited coverage by insurance. Nevertheless, expanding healthcare setup, increasing use of home diagnostics, baby screening programs and improved development of biosensor based bilirubin measurement technologies will offer new opportunities for growth in bilirubin blood test market. Key Features of the Study • This report provides in-depth analysis of the global bilirubin blood test market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global bilirubin blood test market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Sysmex Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Randox Laboratories Ltd., DiaSys Diagnostic Systems GmbH, and EKF Diagnostics Holdings plc • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global bilirubin blood test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bilirubin blood test market Market Segmentation • Test Type Insights (Revenue, USD Bn, 2021 - 2033) o Total Bilirubin Test o Direct Bilirubin Test o Indirect Bilirubin Test • Application Insights (Revenue, USD Bn, 2021 - 2033) o Liver Disease Diagnosis and Monitoring o Neonatal Jaundice Screening o Hemolytic Disorders o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Diagnostic Laboratories o Physician Offices and Clinics o Ambulatory Surgical Centers o Home Care Settings o Others • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o F.Hoffmann-La Roche Ltd. o Abbott Laboratories o Siemens Healthineers AG o Danaher Corporation o Sysmex Corporation o Thermo Fisher Scientific Inc. o bioMérieux SA o Randox Laboratories Ltd. o DiaSys Diagnostic Systems GmbH o EKF Diagnostics Holdings plc

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Bilirubin Blood Test Market, By Test Type  Global Bilirubin Blood Test Market, By Application  Global Bilirubin Blood Test Market, By End User  Global Bilirubin Blood Test Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Bilirubin Blood Test Market, By Test Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Total Bilirubin Test  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Direct Bilirubin Test  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Indirect Bilirubin Test  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Bilirubin Blood Test Market, By Application, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Liver Disease Diagnosis and Monitoring  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Neonatal Jaundice Screening  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Hemolytic Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Bilirubin Blood Test Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Physician Offices and Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Home Care Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Bilirubin Blood Test Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o F.Hoffmann-La Roche Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Siemens Healthineers AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Danaher Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sysmex Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Thermo Fisher Scientific Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o bioMérieux SA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Randox Laboratories Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o DiaSys Diagnostic Systems GmbH  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o EKF Diagnostics Holdings plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 9. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Bilirubin Blood Test Market' - Global forecast to 2033

提及公司

F.Hoffmann-La Roche Ltd.Abbott LaboratoriesSiemens Healthineers AGDanaher CorporationSysmex CorporationThermo Fisher Scientific Inc.bioMérieux SARandox Laboratories Ltd.DiaSys Diagnostic Systems GmbHEKF Diagnostics Holdings plc

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們